Luke Sergott
Stock Analyst at Barclays
(2.21)
# 2,695
Out of 4,876 analysts
291
Total ratings
42.73%
Success rate
-5.89%
Average return
Main Sectors:
Stocks Rated by Luke Sergott
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PACB Pacific Biosciences of California | Maintains: Equal-Weight | $2 → $1.5 | $1.30 | +15.38% | 5 | Jun 25, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Equal-Weight | $475 → $450 | $413.00 | +8.96% | 25 | Jun 24, 2025 | |
| SHC Sotera Health Company | Maintains: Overweight | $15 → $13 | $11.41 | +13.94% | 20 | Jun 24, 2025 | |
| ILMN Illumina | Maintains: Underweight | $77 → $85 | $95.00 | -10.53% | 18 | Jun 24, 2025 | |
| EXAS Exact Sciences | Maintains: Overweight | $75 → $65 | $51.56 | +26.07% | 5 | Jun 24, 2025 | |
| DHR Danaher | Maintains: Overweight | $215 → $225 | $202.67 | +11.02% | 40 | Jun 24, 2025 | |
| A Agilent Technologies | Maintains: Equal-Weight | $115 → $125 | $119.87 | +4.28% | 9 | Jun 24, 2025 | |
| TXG 10x Genomics | Maintains: Overweight | $12 → $13 | $11.72 | +10.92% | 12 | Jun 24, 2025 | |
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $245 | $217.76 | +12.51% | 1 | Jun 24, 2025 | |
| RGEN Repligen | Initiates: Overweight | $150 | $124.41 | +20.57% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $55 | $48.02 | +14.54% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $1,325 | $1,196.40 | +10.75% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Equal-Weight | $300 | $313.75 | -4.38% | 1 | Jun 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $6 → $5 | $5.25 | -4.76% | 10 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $160 → $190 | $168.31 | +12.89% | 3 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $11 → $14 | $11.54 | +21.32% | 17 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $155 | $152.41 | +1.70% | 6 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $46 | $41.93 | +9.71% | 4 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $170 → $165 | $158.45 | +4.14% | 22 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $165 → $155 | $147.06 | +5.40% | 19 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 → $60 | $50.26 | +19.38% | 3 | May 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $18 → $15 | $13.84 | +8.38% | 24 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $400 → $350 | $355.98 | -1.68% | 18 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $58 → $45 | $37.05 | +21.47% | 17 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $140 → $110 | $98.83 | +11.30% | 9 | Apr 10, 2025 |
Pacific Biosciences of California
Jun 25, 2025
Maintains: Equal-Weight
Price Target: $2 → $1.5
Current: $1.30
Upside: +15.38%
Thermo Fisher Scientific
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $475 → $450
Current: $413.00
Upside: +8.96%
Sotera Health Company
Jun 24, 2025
Maintains: Overweight
Price Target: $15 → $13
Current: $11.41
Upside: +13.94%
Illumina
Jun 24, 2025
Maintains: Underweight
Price Target: $77 → $85
Current: $95.00
Upside: -10.53%
Exact Sciences
Jun 24, 2025
Maintains: Overweight
Price Target: $75 → $65
Current: $51.56
Upside: +26.07%
Danaher
Jun 24, 2025
Maintains: Overweight
Price Target: $215 → $225
Current: $202.67
Upside: +11.02%
Agilent Technologies
Jun 24, 2025
Maintains: Equal-Weight
Price Target: $115 → $125
Current: $119.87
Upside: +4.28%
10x Genomics
Jun 24, 2025
Maintains: Overweight
Price Target: $12 → $13
Current: $11.72
Upside: +10.92%
West Pharmaceutical Services
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $245
Current: $217.76
Upside: +12.51%
Repligen
Jun 24, 2025
Initiates: Overweight
Price Target: $150
Current: $124.41
Upside: +20.57%
Jun 24, 2025
Initiates: Overweight
Price Target: $55
Current: $48.02
Upside: +14.54%
Jun 24, 2025
Initiates: Overweight
Price Target: $1,325
Current: $1,196.40
Upside: +10.75%
Jun 24, 2025
Initiates: Equal-Weight
Price Target: $300
Current: $313.75
Upside: -4.38%
May 13, 2025
Maintains: Underweight
Price Target: $6 → $5
Current: $5.25
Upside: -4.76%
May 9, 2025
Maintains: Overweight
Price Target: $160 → $190
Current: $168.31
Upside: +12.89%
May 8, 2025
Upgrades: Overweight
Price Target: $11 → $14
Current: $11.54
Upside: +21.32%
May 8, 2025
Maintains: Equal-Weight
Price Target: $145 → $155
Current: $152.41
Upside: +1.70%
May 8, 2025
Maintains: Overweight
Price Target: $50 → $46
Current: $41.93
Upside: +9.71%
May 7, 2025
Maintains: Equal-Weight
Price Target: $170 → $165
Current: $158.45
Upside: +4.14%
May 2, 2025
Maintains: Equal-Weight
Price Target: $165 → $155
Current: $147.06
Upside: +5.40%
May 1, 2025
Maintains: Overweight
Price Target: $55 → $60
Current: $50.26
Upside: +19.38%
Apr 28, 2025
Maintains: Overweight
Price Target: $18 → $15
Current: $13.84
Upside: +8.38%
Apr 10, 2025
Maintains: Equal-Weight
Price Target: $400 → $350
Current: $355.98
Upside: -1.68%
Apr 10, 2025
Maintains: Overweight
Price Target: $58 → $45
Current: $37.05
Upside: +21.47%
Apr 10, 2025
Maintains: Overweight
Price Target: $140 → $110
Current: $98.83
Upside: +11.30%